Loading clinical trials...
Loading clinical trials...
A Pilot Study of Biomarker Evaluation and Safety of Pre-Incisional Ketorolac for Patients Undergoing Surgical Resection for Non-Small Cell Lung Cancer and Renal Cell Carcinoma
Conditions
Interventions
Preoperative Ketorolac
Locations
4
United States
Emory University Hospital Midtown
Atlanta, Georgia, United States
Emory Clinic
Atlanta, Georgia, United States
Emory University Hospital
Atlanta, Georgia, United States
Winship Cancer Institute
Atlanta, Georgia, United States
Start Date
August 24, 2020
Primary Completion Date
February 1, 2024
Completion Date
February 1, 2024
Last Updated
March 4, 2025
NCT07227402
NCT06043817
NCT07144280
NCT06758401
NCT05969860
NCT07431827
Lead Sponsor
Emory University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions